Canadian Researchers Secure Major Funding for Revolutionary Multiple Sclerosis Treatment
A Canadian-led international research team has achieved a significant milestone in the fight against multiple sclerosis, securing nearly $800,000 US in funding to advance what could become the first potentially regenerative treatment for this devastating neurological condition. The breakthrough research, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH), represents […]
Is Regenerative Medicine Covered by Insurance? The Complete 2025 Guide
Are you considering regenerative medicine treatments but worried about the cost? You’re not alone. Thousands of patients face the same question every day: will my insurance cover stem cell therapy, PRP injections, or other regenerative treatments? The answer is more complicated than a simple yes or no, and understanding the current insurance landscape could save you thousands […]
Breakthrough in Alzheimer’s Treatment: Lomecel-B™ Receives RMAT Designation from FDA
Longeveron Inc., a clinical stage regenerative medicine biotechnology company, has achieved a significant milestone in the fight against Alzheimer’s Disease. The U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to Lomecel-B™ for the treatment of mild Alzheimer’s Disease. This designation underscores the potential of Lomecel-B™ to provide a new […]
Revolutionary Cell Therapy Shows Promise: Over 90% Seizure Reduction in Drug-Resistant Epilepsy Patients
Neurona Therapeutics, a clinical-stage biotherapeutics company, is developing regenerative cell therapies for the treatment of neurological disorders. They recently presented updated clinical data from their ongoing Phase I/II trial of NRTX-1001 in people with drug-resistant mesial temporal lobe epilepsy (MTLE) at the American Academy of Neurology 2023 Annual Meeting. The data showed a >90% reduction […]
Neurona Therapeutics Presents Encouraging Clinical Data from First-Ever Regenerative Human Cell Therapy Trial in Adults with Drug-Resistant Focal Epilepsy and Shows Supporting Manufacturing, Delivery, and Preclinical Data
SAN FRANCISCO, Nov. 21, 2022 (GLOBE NEWSWIRE) — Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for the treatment of neurological disorders, announced that Cory R. Nicholas, Ph.D., Neurona’s president and chief executive officer, was invited to present an overview of Neurona’s regenerative cell therapy technology, proprietary manufacturing process, cell delivery system, and preclinical […]